Patient Profile: 53-Year-Old Man with Heavily Pre-Treated MM including T-cell Directed Therapy
September 4th 2024
The panel presents and analyzes a case study of a 53-year-old man with heavily pre-treated multiple myeloma, including chemotherapy – based therapy and prior T-cell directed therapy, to illustrate treatment considerations and challenges in advanced disease management.